Free Trial

Trellus Health (TRLS) Competitors

GBX 1.90 +0.05 (+2.70%)
As of 11:31 AM Eastern

TRLS vs. INHC, FDBK, IQAI, DVRG, SENS, EMIS, CRW, INS, KOO, and RENX

Should you be buying Trellus Health stock or one of its competitors? The main competitors of Trellus Health include Induction Healthcare Group (INHC), Feedback (FDBK), IQ-AI (IQAI), DeepVerge (DVRG), Sensyne Health (SENS), EMIS Group (EMIS), Craneware (CRW), Instem (INS), Kooth (KOO), and Renalytix (RENX). These companies are all part of the "health information services" industry.

Trellus Health vs.

Trellus Health (LON:TRLS) and Induction Healthcare Group (LON:INHC) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, valuation, earnings, media sentiment, analyst recommendations, risk and community ranking.

19.3% of Trellus Health shares are held by institutional investors. Comparatively, 46.3% of Induction Healthcare Group shares are held by institutional investors. 49.7% of Trellus Health shares are held by company insiders. Comparatively, 54.6% of Induction Healthcare Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Induction Healthcare Group received 14 more outperform votes than Trellus Health when rated by MarketBeat users.

CompanyUnderperformOutperform
Trellus HealthN/AN/A
Induction Healthcare GroupOutperform Votes
14
93.33%
Underperform Votes
1
6.67%

Induction Healthcare Group has a net margin of -40.70% compared to Trellus Health's net margin of -12,114.55%. Induction Healthcare Group's return on equity of -26.97% beat Trellus Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Trellus Health-12,114.55% -37.95% -22.76%
Induction Healthcare Group -40.70%-26.97%-7.32%

Induction Healthcare Group has higher revenue and earnings than Trellus Health. Induction Healthcare Group is trading at a lower price-to-earnings ratio than Trellus Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Trellus Health£65.83K55.80-£7.98M-£3.45-0.55
Induction Healthcare Group£12.57M0.70-£5.12M-£5.54-1.73

In the previous week, Trellus Health's average media sentiment score of 0.00 equaled Induction Healthcare Group'saverage media sentiment score.

Company Overall Sentiment
Trellus Health Neutral
Induction Healthcare Group Neutral

Trellus Health has a beta of 0.01, meaning that its share price is 99% less volatile than the S&P 500. Comparatively, Induction Healthcare Group has a beta of -0.41, meaning that its share price is 141% less volatile than the S&P 500.

Summary

Induction Healthcare Group beats Trellus Health on 8 of the 12 factors compared between the two stocks.

Get Trellus Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for TRLS and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

TRLS vs. The Competition

MetricTrellus HealthHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£3.67M£212.34M£5.36B£2.68B
Dividend YieldN/A6.68%5.22%5.05%
P/E Ratio-0.55318.7126.59134.32
Price / Sales55.80454.52391.61203,702.45
Price / Cash0.7647.1438.2528.02
Price / Book0.205.346.793.79
Net Income-£7.98M-£15.55M£3.23B£5.89B
7 Day Performance10.47%1.34%4.03%7.78%
1 Month Performance-5.00%7.53%12.22%29.45%
1 Year Performance24.59%7.23%16.76%119.74%

Trellus Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
TRLS
Trellus Health
N/AGBX 1.90
+2.7%
N/A+15.9%£3.67M£65,831.01-0.5531Gap Up
INHC
Induction Healthcare Group
N/AGBX 9.60
+1.1%
N/A-16.9%£8.86M£12.57M-1.7374Gap Down
FDBK
Feedback
N/AGBX 13.55
-1.5%
N/A-81.6%£5.94M£3.88M-0.5524
IQAI
IQ-AI
N/AGBX 0.85
+3.0%
N/A-42.9%£1.89M£538,190.00-13.676Gap Up
DVRG
DeepVerge
N/AN/AN/AN/A£1.14M£12.41M-15.0073
SENS
Sensyne Health
N/AN/AN/AN/A£583,000.00£7.81M-0.0270Gap Down
EMIS
EMIS Group
N/AN/AN/AN/A£1.23B£176.86M4,085.111,560
CRW
Craneware
2.7604 of 5 stars
GBX 1,793.50
-0.9%
GBX 2,800
+56.1%
+1.4%£770.61M£230.77M66.26734
INS
Instem
N/AN/AN/AN/A£199.62M£61.63M5,928.57500
KOO
Kooth
N/AGBX 131.50
-2.6%
GBX 456.67
+247.3%
-53.3%£48.26M£50.72M12.35478Gap Up
High Trading Volume
RENX
Renalytix
N/AGBX 8.05
+0.6%
N/A-63.6%£33.37M£9.22M-0.38102

Related Companies and Tools


This page (LON:TRLS) was last updated on 5/21/2025 by MarketBeat.com Staff
From Our Partners